Prospective, Observational, Non-interventional, Multicenter Study on the Efficacy and Tolerability of Calcipotriol/Betamethasone Aerosol Foam (Enstilar®) in Patients With Plaque Psoriasis Under Daily Practice Conditions
Phase of Trial: Phase IV
Latest Information Update: 07 Aug 2017
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- Sponsors LEO Pharma
- 03 Aug 2017 Status changed from active, no longer recruiting to completed.
- 29 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Apr 2017.
- 29 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Apr 2017.